Skip to Main Content

PETER C. ALBERTSEN, MD, Division of Urology, University of Connecticut Health Center, Farmington, Connecticut, USA

OMAR AL-SALIHI, BSc MBBS MRCP FRCR, Consultant Oncologist, University College London Hospital, London, UK

ANDREW J. ARMSTRONG, MDScM, Duke Comprehensive Cancer Center, Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina, USA

DENISE C. BABINEAU, PhD, Assistant Staff, Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio, USA

DAVID G. BOSTWICK, MD MBA FCAP, CEO, President, Medical Director, Bostwick Laboratories, Glen Allen, Virginia, USA

JAMES D. BROOKS, MD, Associate Professor, Department of Urology, Stanford University School of Medicine, Stanford, California, USA

ARTHUR L. BURNETT, MD, Department of Urology, Johns Hopkins Hospital, Baltimore, Maryland, USA

MICHAEL A. CARDUCCI, MD ScM, Associate Professor of Oncology and Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA

STEVEN L. CHANG, MD, Department of Urology, Stanford University School of Medicine, Stanford, California, USA

KIM N. CHI, MD FRCP[C], Assistant Professor, Department of Medicine, Division of Medical Oncology, University of British Columbia, Medical Director-Vancouver Centre Clinical Trials Unit, BC Cancer Agency, Vancouver, British Columbia, Canada

CHRISTOPHER FARNHAM, MB BS BSc FRCP, Consultant in Palliative Care, St John’s Hospice, Hospital of St John and St Elizabeth, London, UK

MARK R. FENELEY, MD(Cantab) FRCS(Eng) FRCS(Urol), Senior Lecturer in Urological Oncological Surgery, University College London, London, UK

ADRIAN C. GARDNER, FRCS, Specialist Registrar in Orthopaedics and Trauma, Royal Orthopaedic Hospital NHS Trust, Birmingham, UK

ROBERT H. GETZENBERG, PhD, Director of Urology Research, Professor, Urology and Oncology, The Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland, USA

DAVID GILLAT, ChM FRCS, Consultant Urologist, The Cotswold Centre, Southmead, Bristol, UK

MARTIN E. GLEAVE, MD FRCS[C], Professor, Department of Urological Sciences, University of British Columbia, Director of Research, The Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada

MICHAEL W. KATTAN, PhD, Chairman, Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio, USA

BRUCE R. KAVA, MD, Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA

VINCENT KHOO , MBBS FRACR FRCR MD, Consultant and Honorary Senior Lecturer in Clinical Oncology, Department of Radiotherapy and Oncology, Royal Marsden Hospital & Institute of Cancer Research, London, UK

ROGER S. KIRBY, MA MD FRCS (Urol), The Prostate Centre, London, UK

LAURENCE KLOTZ, MD FRCSC, Chief, Division of Urology, Sunnybrook and Women’s College Health Sciences Centre, Toronto, Ontario, Canada

EDDY S. LEMAN, PhD, The Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland, USA

FAYE LIM, MB BS BSc MRCP, Specialist Registrar in Oncology, University College London Hospital, London, UK

SARAH MARIETTI, MD, Division of Urology, University of Connecticut Health Center, Farmington, Connecticut, USA

ISABELLE MEIERS, MD, Bostwick Laboratories, Regents Park, London, UK

ANITA MITRA, MBBS MRCP FRCR, Clinical Research Fellow, Institute of Cancer Research, Sutton, UK

DON NEWLING, MBBChir. FRCS, Medical Director (Oncology), AstraZeneca, Alderley Park, Macclesfield, UK

ALAN M. NIEDER, MD, Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA

JOE O’SULLIVAN, MD FRCPI FFRRCSI, Consultant/Senior Lecturer in Oncology, The Northern Ireland Cancer Centre, Centre for Cancer Research and Cell Biology, Queen’s University Belfast, Belfast City Hospital, Belfast, UK

HEATHER A. PAYNE, MB BS FRCP RRCR, Consultant Oncologist, Meyerstein, Institute of Urology, University College London, London, UK

COLIN PURCELL, MB MRCP, Specialist Registrar in Medical Oncology, The Northern Ireland Cancer Centre, Centre for Cancer Research and Cell Biology, Queen’s University Belfast, Belfast City Hospital, Belfast, UK

MARK S. SOLOWAY, MD, Professor and Chairman, Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA

ALISTAIR J. STIRLING, FRCS, Consultant Spinal Surgeon, Royal Orthopaedic Hospital NHS Trust, Birmingham, UK

ROGER M. TILMAN, FRCS, Consultant Orthopaedic Oncologist, Royal Orthopaedic Hospital NHS Trust, Birmingham, UK

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.